enzalutamide

CD274 molecule ; Homo sapiens







7 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35013615 Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial. 2022 Jan 1
2 34011528 Flightless I Homolog Reverses Enzalutamide Resistance through PD-L1-Mediated Immune Evasion in Prostate Cancer. 2021 Jul 3
3 34945784 What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 7: PD-L1 Expression in Liquid Biopsy. 2021 Dec 6 1
4 32616555 A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone. 2020 Jul 2
5 30610805 The expression of PD-L1 in patients with castrate prostate cancer treated with enzalutamide. 2018 Nov-Dec 2
6 28893901 Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide. 2017 Nov 15 1
7 25428917 PD-L1 is highly expressed in Enzalutamide resistant prostate cancer. 2015 Jan 1 1